Filing Details

Accession Number:
0001225208-20-001874
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-10 16:56:07
Reporting Period:
2020-02-06
Accepted Time:
2020-02-10 16:56:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
21665 Colgate Palmolive Co CL Perfumes, Cosmetics & Other Toilet Preparations (2844) 131815595
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1333720 B Daniel Marsili C/O Colgate-Palmolive Company
300 Park Avenue
New York NY 10022
Chief Human Resources Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-06 66,843 $64.00 122,586 No 4 M Direct
Common Stock Disposition 2020-02-06 66,843 $76.30 55,743 No 4 S Direct
Common Stock Disposition 2020-02-07 4,763 $76.03 25,902 No 4 I Indirect By Issuer's 401(k) Plan Trustee
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 I Indirect By Issuer's 401(k) Plan Trustee
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-02-06 66,843 $0.00 66,843 $64.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-09-10 No 4 M Direct
Footnotes
  1. Exercise of stock options awarded under the issuer's incentive compensation plan.
  2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's employee stock option plan and the related tax withholding.
  3. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $75.97 to $76.44, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. Transfer of funds within the issuer's 401(k) plan from Company stock to another investment option.
  5. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2014, grant date.